BioFilm Pharma brings its innovative approach by addressing the chronic disease and long-term treatment “diabete foot ulcers” (15 million new patients each year), which represent a heavy cost for Health Care system in high-income countries ($4...

Sandoz is a global leader in generic pharmaceuticals and biosimilars and a division of the Novartis Group. Our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare...

At T2 Biosystems, our mission is to improve sepsis management by empowering clinicians to appropriately treat patients suspected of bloodstream infections faster than ever before. Early targeted therapy for pathogenic organisms may prevent...

Motif Bio is a clinical stage biopharmaceutical company which specializes in developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Iclaprim is being developed...

Venus Remedies Limited (VRL) is a fully integrated, research-driven Indian Pharmaceutical company with global footprints. Since 2004, Venus has been spearheading the Infectious Diseases research in India, focusing on preserving the life of existing...

Synthetic Biologics, Inc. (NYSE MKT: SYN) is a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients. The Company's lead candidates poised for Phase 3 development are: (1)...

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research...

Peptilogics is a preclinical stage company developing a platform technology supporting a new class of broad-spectrum synthetic, engineered peptide antibiotics for multidrug-resistant (MDR) bacterial infections. We have demonstrated in vitro...

Alphanosos leverages its disruptive, Artificial Intelligence (AI) based, proprietary discovery process to elaborate and patent active Water Extracts of Complex Mixes of Edible Plants (WECMEPs) and develop human and animal therapeutic solutions with...

 Phagelux utilizes phages, lysins and other biologics and related delivery technologies to create antibacterial products and solutions. Phagelux is headquartered in Shanghai with laboratories in China and North America and manufacturing facilities...

Shield Diagnostics is using precision medicine to ensure antibiotic resistance doesn’t become deadlier than cancer. Shield Dx's novel genomic testing platform provides a full antibiotic resistance profile of a pathogen for the same cost and time ...

Streck develops and manufactures hematology, immunology and molecular biology products for clinical and research laboratories. Innovative products include ARM-D® kits for antibiotic resistance monitoring and detection, PhilisaFAST® DNA...